The Neuropsychology of Pediatric Epilepsy and Antiepileptic Drugs

  • Thomas L. Bennett
  • Maile R. Ho

Epilepsy is a nervous system disturbance that abruptly interferes with ongoing behavior, perception, movement, consciousness, or other brain functions. Individual attacks are called seizures, and when the problem is consistent it is called either a seizure disorder or epilepsy.


Temporal Lobe Partial Seizure Seizure Frequency Ketogenic Diet Seizure Disorder 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Abou-Khalil, B., Shellenberger, M. K., & Anhut, H. (1992). Two open-label, multicenter studies of the safety and efficacy of gabapentin in patients with refractory epilepsy. Epilepsia, 33, 77.Google Scholar
  2. American Academy of Pediatrics. (1985). Behavioral and cognitive effects of anticonvulsant therapy. Pediatrics, 76(4), 644-647.Google Scholar
  3. Andrewes, D. G., Tomlinson, L., Elwes, R. D., & Reynolds, E. H. (1984). The influence of carbamazepine and phenytoin on memory and other aspects of cognitive function in new referrals with epilepsy. Acta Neurologica Scandinavica, 69(Suppl. 99), 23-30.Google Scholar
  4. Arieff, A. J., & Yacorzynski, G. K. (1942). Deterioration of patients with organic epilepsy. Journal of Nervous and Mental Disease, 96, 49-55.Google Scholar
  5. Austin, J. K., Smith, M. S., Risinger, M. W., & McNelis, A. M. (1994). Childhood epilepsy and asthma: Comparison of quality of life. Epilepsia, 35(3), 608-615.PubMedGoogle Scholar
  6. Bagley, C. (1971). The social psychology of the child with epilepsy. London: Routledge & Kegan Paul.Google Scholar
  7. Barnes, S. E., & Bower, B. D. (1975). Sodium valproate in the treatment of intactable childhood epilepsy. Developmental Medicine and Child Neurology, 17, 175-181.PubMedGoogle Scholar
  8. Batzel, L. W., Dodrill, C. B., Dubinsky, B. L., Ziegler, R. G., Connolly, J. E., Freeman, R. D., et al. (1991). An objective method for the assessment of psychosocial problems in adolescents with epilepsy. Epilepsia, 32(2), 202-211.PubMedGoogle Scholar
  9. Bauer, G., Bechinger, D., Castell, M., Deisenhammer, E., & Egli, M. (1989). Gabapentin in the treatment of drug-resistant epileptic patients. Advances in Epileptology, 17, 219-221.Google Scholar
  10. Bear, D. M. (1979). Temporal lobe epilepsy: A syndrome of sensory-limbic hyperconnection. Cortex, 15, 357-384.PubMedGoogle Scholar
  11. Bear, D. M., & Fedio, P. (1977). Quantitative analysis of interictal behavior in temporal lobe epilepsy. Archives of Neurology, 34, 454-467.PubMedGoogle Scholar
  12. Bear, D. M., Freeman, R., & Greenberg, M. (1984). Behavioral alterations in patients with temporal lobe epilepsy. In D. Blumer (Ed.), Psychiatric aspects of epilepsy (pp. 197-227). Washington, DC: American Psychiatric Press.Google Scholar
  13. Bellur, S., & Hermann, B. P. (1984). Emotional and cognitive effects of anticonvulsant medications. The International Journal of Clinical Neuropsychology, 6, 21-23.Google Scholar
  14. Ben-Menachem, E., Persson, L. I., Schechter, P. J., Haegele, K. D., Huebert, N., Hardenberg, J., et al. (1989). The effect of different vigabatrin treatment regimens on CSF biochemistry and seizure control in epileptic patients. British Journal of Clinical Pharmacy, 27, 79S-85S.Google Scholar
  15. Bennett, T. L. (1987). Neuropsychological aspects of complex partial seizures: Diagnostic and treatment issues. The International Journal of Clinical Neuropsychology, 9(1), 37-45.Google Scholar
  16. Bennett, T. L. (1988). Use of the Halstead-Reitan Neuropsychological Test Battery in the assessment of head injury. Cognitive Rehabilitation, May/June, 6(3), 18-24.Google Scholar
  17. Betts, T., Goodwin, G., Withers, R. M., & Yuen, A. W. C. (1991). Human safety of lamotrigine. Human safety of lamotrigine. Epilepsia, 32(Suppl. 2), S17-S19.PubMedGoogle Scholar
  18. Beyers, V. L. (1993). Novel antiepileptic drugs: Nursing implications. Journal of Neuroscience Nursing, 25(6), 375-379.Google Scholar
  19. Blumer, D., & Benson, D. F. (1982). Psychiatric manifestations of epilepsy. In D. F. Benson & D. Blumer (Eds.), Psychiatric aspects of neurological disease (Vol. 2, pp. 25-48). New York: Grune & Stratton.Google Scholar
  20. Browne, S. W., & Reynolds, E. H. (1981). Cognitive impairment in epileptic patients. In E. H. Reynolds & M. R. Trimble (Eds.), Epilepsy and psychiatry (pp. 147-164). London: Churchill Livingstone.Google Scholar
  21. Browne, T. (1993). Long-term efficacy and toxicity of gabapentin. Neurology, 43, A307.Google Scholar
  22. Browne, T. R., Dreifuss, F. E., Dyken, P. R., Goode, D. J., Penry, J. K., Porter, R. J., et al. (1975). Ethosuccimide in the treatment of absences (petit mal) seizures. Neurology, 25, 515-525.PubMedGoogle Scholar
  23. Browne, T. R., Mattson, P. H., Penry, J. K., Smith, D. B., Treiman, D. M., Wilder, B. J., et al. (1989). A multicentre study of vigabatrin for drug-resistant epilepsy. British Journal of Clinical Pharmacy, 27, 95S-100S.Google Scholar
  24. Bruhm, P., & Parsons, O. A. (1977). Reaction time variability in epileptic and brain-damaged patients. Cortex, 13, 373-384.Google Scholar
  25. Committee on Drugs. (1985). Behavioral and cognitive effects of anticonvulsant therapy. Pediatrics, 76, 644-647.Google Scholar
  26. Corbett, J. A., Trimble, M. R., & Nichol, T. C. (1985). Behavioral and cognitive impairments in children with epilepsy: The long-term effects of anticonvulsant therapy. Journal of the American Academy of Child Psychiatry, 24, 17-23.PubMedGoogle Scholar
  27. Crawford, P., Ghadiel, E., Lane, R., Blumhardt, L., & Chadwick, D. (1987). Gabapentin as an antiepileptic drug in man. Journal of Neurology, Neurosurgery, and Psychiatry, 49, 1251-1257.Google Scholar
  28. Dalby, M. A. (1975). Behavioral effects of carbamazepine. In J. K. Penry & D. D. Daly (Eds.), Advances in Neurology (Vol. 11, pp. 331-343). New York: Raven Press.Google Scholar
  29. Davidson, D. L. W. (1983). A review of the side effects of sodium valproate. British Journal of Clinical Practice, 27(Suppl.), 79-85.Google Scholar
  30. Dean, J. C. (1993). Valproate. In E. Wyllie (Ed.), The treatment of epilepsy: Principles and practices (pp. 915-923). Philadelphia: Lea & Febiger.Google Scholar
  31. Delaney, R. C., Rosen, A. J., Mattson, R. H., & Novelly, R. A. (1980). Memory function in focal epilepsy: A comparison of non-surgical, unilateral temporal lobe and frontal lobe samples. Cortex, 16, 103-117.PubMedGoogle Scholar
  32. Dewhurst, K. (1980). Thomas Willis’ Oxford Lectures. Oxford: Sanford.Google Scholar
  33. Dikmen, S., & Matthews, C. G. (1977). Effect of major motor seizure frequency upon cognitive-intellectual function in adults. Epilepsia, 18, 21-29.PubMedGoogle Scholar
  34. Dikmen, S., Matthews, C. G., & Harley, J. P. (1977). Effect of early versus late onset of major motor epilepsy upon cognitive-intellectual function in adults. Epilepsia, 16, 73-81.Google Scholar
  35. Dikmen, S., & Reitan, R. (1978). Neuropsychological performance in posttraumatic epilepsy. Epilepsia, 18, 31-36.Google Scholar
  36. Dodrill, C. B. (1978). A neuropsychological battery for epilepsy. Epilepsia, 19, 611-623.PubMedGoogle Scholar
  37. Dodrill, C. B. (1981). Neuropsychology of epilepsy. In S. B. Filskov & T. J. Boll (Eds.), Handbook of clinical neuropsychology (pp. 366-395). New York: Wiley.Google Scholar
  38. Dodrill, C. B., & Troupin, A. S. (1977). Psychotropic effects of carbamazepine in epilepsy: A double-blind comparison with phenytoin. Neurology, 27, 1023-1028.PubMedGoogle Scholar
  39. Dodrill, C. B., & Troupin, A. S. (1991). Neuropsychological effects of carbamazepine and phenytoin: A reanalysis. Neurology, 41, 141-143.PubMedGoogle Scholar
  40. Dodrill, C. B., Wilensky, A. J., Ojeman, L., Temkin, N., & Shellenberger, K. (1992). Neuropsychological, mood, and psychosocial effects of gabapentin. Epilepsia, 33, 117-118.Google Scholar
  41. Dodson, W. E., & Pellock, J. M. (Eds.). (1993). Pediatric epilepsy: Diagnosis and therapy. New York: Demos.Google Scholar
  42. Dulac, O., Withers, R. M., & Yuen, A. W. C. (1991). Add-on lamotrigine in pediatric patients with resistant epilepsy (Abstract). Epilepsia, 32 (Suppl. 3), 10.Google Scholar
  43. Duncan, J. S., Shorvon, S. D., & Trimble, M. R. (1990). Effects of removal of phenytoin, carbamazepine, and valproate on cognitive function. Epilepsia, 31(5), 584-591.PubMedGoogle Scholar
  44. Farwell, J. R., Dodrill, C. B., & Batzel, L. W. (1985). Neuropsychological abilities in children with epilepsy. Epilepsia, 26(5), 395-400.PubMedGoogle Scholar
  45. Farwell, J. R., Lee, Y. J., Hirtz, D. G., Sulzbacher, S. I., Ellenberg, J. H., & Nelson, K. B. (1990). Phenobarbital for febrile seizures: Effects on intelligence and on seizure recurrence. New England Journal of Medicine, 322, 364-369.PubMedGoogle Scholar
  46. Fedio, P., & Mirsky, A. F. (1969). Selective intellectual deficits in children with temporal lobe or centrencephalic epilepsy. Neuropsychologia, 7, 287-300.Google Scholar
  47. Fischbacher, E. (1982). Effect of reduction of anticonvulsants on wellbeing. British Medical Journal, 285, 425-427.Google Scholar
  48. Fisher, R. S. (1993). Emerging antiepileptic drugs. Neurology, 43(Suppl. 5), S12-S20.PubMedGoogle Scholar
  49. Fowler, P. C., Richards, H. C., Berent, S., & Boll, T. J. (1987). Epilepsy, neuropsychological deficits, and EEG lateralization. Archives of Clinical Neuropsychology, 2, 81-92.PubMedGoogle Scholar
  50. Fox, J. T. (1924). Response of epileptic children to mental and educational tests. British Journal of Medical Psychology, 4, 235-248.Google Scholar
  51. Freeman, J. M., Vining, E. P. G., & Pillas, D. J. (1990). Seizures and epilepsy in childhood: A guide for parents. Baltimore: Johns Hopkins University Press.Google Scholar
  52. Geschwind, N. (1984). Dostoievsky's epilepsy. In D. Blumer (Ed.), Psychiatric aspects of epilepsy (pp. 325-334). Washington, DC: American Psychiatric Press.Google Scholar
  53. Gillham, R. A., Blacklaw, J., McKee, P. J. W., & Brodie, M. J. (1993). Effect of vigabatrin on sedation and cognition function in patients with refractory epilepsy. Journal of Neurology, Neurosurgery, and Psychiatry, 56, 1271-1275.PubMedGoogle Scholar
  54. Giordani, B., Berent, S., Sackellares, J. C., Rourke, D., Seidenberg, M., O'Leary, D. S., et al. (1985). Intelligence test performance of patients with partial and generalized seizures. Epilepsia, 26(1), 37-42.PubMedGoogle Scholar
  55. Glowinski, H. (1973). Cognitive deficits in temporal lobe epilepsy. The Journal of Nervous and Mental Disorders, 157, 129-137.Google Scholar
  56. Goode, D. J., Penry, J. J., & Dreifuss, F. E. (1970). Effects of paroxysmal spike wave on continuous visuo-motor performance. Epilepsia, 11, 241-254.PubMedGoogle Scholar
  57. Gram, L. (1989). Potential antiepileptic drugs: Lamotrigine. In R. Levy, F. E. Dreifuss, R. Mattson, B. S. Dreifuss, & J. K. Penry (Eds.), Antiepileptic drugs (3rd ed., pp. 947-953). New York: Raven Press.Google Scholar
  58. Grant, S. M., & Heel, R. C. (1991). Vigabatrin. A review of its pharmacodynamics and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control. Drug, 41, 889-926.Google Scholar
  59. Graves, N. M., & Leppick, I. E. (1991). Antiepileptic medications in development. DICP Annals of Pharmacotherapy, 25, 978-986.Google Scholar
  60. Graves, N. M., & Leppick, I. E. (1993). Advances in pharmacotherapy: Recent developments in the treatment of epilepsy. Journal of Clinical Pharmacy and Therapeutics, 18, 227-242.PubMedGoogle Scholar
  61. Grinker, R. R. (1929). The proper use of phenobarbital in the treatment of the epilepsies. Journal of the American Medical Association, 93, 1218-1219.Google Scholar
  62. Guey, J., Charles, C., Coquery, C., Roger, J., & Soulayrol, R. (1967). Study of psychological effects of ethosuximide (Zaraontin) on 25 children suffering from petit mal epilepsy. Epilepsia, 8, 129-141.Google Scholar
  63. Guldvog, B., Løyning, Y., Hauglie-Hanssen, E., Flood, S., & Bjørnaes, H. (1991). Surgical versus medical treatment for epilepsy. I. Outcome related to survival, seizures, and neurologic deficit. Epilepsia, 32(3), 375-388.PubMedGoogle Scholar
  64. Hauser, W. A. (1994). The prevalence and incidence of convulsive disorders in children. Epilepsia, 35(Suppl. 2), s1-s6.PubMedGoogle Scholar
  65. Haynes, S. D., & Bennett, T. L. (1991). Cognitive impairment in adults with complex partial seizures. International Journal of Clinical Neuropsychology, 12, 74-81.Google Scholar
  66. Hendricks, M. (1995, April). High fat and seizure free. Johns Hopkins Magazine, 14-20.Google Scholar
  67. Hermann, B. P., & Whitman, S. (1986). Psychopathology in epilepsy: A multi-etiological model. In S. Whitman & B. P. Hermann (Eds.), Psychopathology in epilepsy: Social dimensions (pp. 5-37). London: Oxford University Press.Google Scholar
  68. Hermann, B. P., Wyler, A. R., & Richey, E. T. (1988). Wisconsin card sorting test performance in patients with complex partial seizures of temporal lobe origin. Journal of Clinical and Experimental Neuropsychology, 10(4), 467-476.PubMedGoogle Scholar
  69. Herranz, J. L., Arteaga, R., Farr, I. N., Valdizan, E., Beaumont, D., & Armijo, J. A. (1991). Dose-response study of vigabatrin in children with refractory epilepsy. Journal of Child Neurology, 6(Suppl.), 2S25-2S51.Google Scholar
  70. Himmelhock, J. M. (1984). Major mood disorders related to epileptic changes. In D. Blumer (Ed.), Psychiatric aspects of epilepsy (pp. 271-294). Washington, DC: American Psychiatric Press.Google Scholar
  71. Holdsworth, L., & Whitmore, K. (1974). A study of children with epilepsy attending ordinary schools, I: Their seizure patterns, progress, and behavior in school. Developmental Medicine and Child Neurology, 16, 746-758.PubMedGoogle Scholar
  72. Hutt, S. J., Jackson, P. M., Belsham, A. B., & Higgins, G. (1968). Perceptual-motor behavior in relation to blood phenobarbitone level. Developmental Medicine and Child Neurology, 10, 626-632.PubMedGoogle Scholar
  73. Idestrom, C. M., Schelling, D., Carlquist, V., & Sjoquist, F. (1972). Behavioral and psychophysiological studies: Acute effects of diphenylhydantoin in relation to plasma levels. Psychological Medicine, 2, 111-120.PubMedGoogle Scholar
  74. Jarvis, P. E., & Barth, J. T. (1984). Halstead-Reitan Test Battery: An interpretative guide. Odessa, FL: Psychological Assessment Resources.Google Scholar
  75. Kalviainen, R., Keranen, T., & Riekkinen, P. J. (1993). Place of newer antiepileptic drugs in the treatment of epilepsy. Drugs, 46(6), 1009-1024.PubMedGoogle Scholar
  76. Keating, L. E. (1960). A review of the literature on the relationship of epilepsy and intelligence in school children. Journal of Mental Science, 106, 1042-1059.PubMedGoogle Scholar
  77. Keith, H. M., Ewert, J. C., Green, M. W., & Gage, R. P. (1955). Mental status of children with convulsive disorders. Neurology, 5, 419-425.PubMedGoogle Scholar
  78. Kinsman, S. L., Vining, E. P. G., Quaskey, S. A., Mellits, D., & Freeman, J. M. (1992). Efficacy of the ketogenic diet for intractable seizure disorders: Review of 58 cases. Epilepsia, 33(6), 1132-1136.PubMedGoogle Scholar
  79. Lansdell, H., & Mirsky, A. F. (1964). Attention in focal and centrencephalic epilepsy. Experimental Neurology, 9, 463-469.PubMedGoogle Scholar
  80. Lantz, D., & Sterman, M. B. (1992). Neuropsychological prediction and outcome measures in relation to EEG feedback training for the treatment of epilepsy. In T. L. Bennett (Ed.), The neuropsychology of epilepsy (pp. 213-222). New York: Plenum Press.Google Scholar
  81. Lavadas, E., Umitta, C., & Provinciali, L. (1979). Hemisphere dependent cognitive performances in epileptic patients. Epilepsia, 20, 493-502.Google Scholar
  82. Lechtenberg, R. (1984). Epilepsy and the family. Cambridge, MA: Harvard University Press.Google Scholar
  83. Lennox, W. G. (1942). Brain injury, drugs, and environment as causes of mental decay in epileptics. American Journal of Psychiatry, 99, 174-180.Google Scholar
  84. Lennox, W. G., & Lennox, M. A. (1960). Epilepsy and related disorders. Boston: Little, Brown.Google Scholar
  85. Livingston, J. H., Beaumont, D., Arzimanoglou, A., & Aicardi, J. (1989). Vigabatrin in the treatment of epilepsy in children. British Journal of Clinical Pharmacology, 27(Suppl. 1), 109S-112S.PubMedGoogle Scholar
  86. Loiseau, P., Signoret, J. L., & Strube, E. (1984). Attention problems in adult epileptic patients. Acta Neurologica Scandinavia, 69(Suppl. 99), 31-34.Google Scholar
  87. Loiseau, P., Strube, E., Brouslet, D., Battellochi, S., Gomeni, C., & Morselli, P. L. (1980). Evaluation of memory function in a population of epileptic patients and matched controls. Acta Neurologica Scandinavia, 62(Suppl. 80), 58-61.Google Scholar
  88. Long, C. G., & Moore, J. T. (1979). Parental expectations for their epileptic children. Journal of Child Psychology and Psychiatry, 20, 313-324.Google Scholar
  89. McGowan, M. E. L., Neville, B. G. R., & Reynolds, E. H. (1983). Comparative monotherapy trial in children with epilepsy. British Journal of Clinical Practice, 27(Symp. Suppl.), 115-118.Google Scholar
  90. McGuckin, H. M. (1980). Changing the world view of those with epilepsy. In R. Canger, F. Angeleri, & J. K. Penry (Eds.), Advances in epileptology: Eleventh epilepsy international symposium (pp. 205-208). New York: Raven Press.Google Scholar
  91. McGuire, A. M., Duncan, J. S., & Trimble, M. R. (1992). Effects of vigabatrin on cognitive function and mood, when used as add-on therapy in patients with intractable epilepsy. Epilepsia, 33, 128-134.PubMedGoogle Scholar
  92. MacLeod, C. M., Dekaban, A., & Hunt, E. (1978). Memory impairment in epileptic patients: Selective effects of phenobarbital concentration. Science, 202, 1102-1104.PubMedGoogle Scholar
  93. Masui, K., Niwa, S., Anzai, N., Kameyama, T., Saitoh, O., & Rymar, K. (1984). Verbal memory disturbances in left temporal lobe epileptics. Cortex, 20, 361-368.PubMedGoogle Scholar
  94. Matthews, C. G., & Kløve, H. (1967). Differential psychological performances in motor, psychomotor, and mixed seizure classification of known and unknown etiology. Epilepsia, 8, 117-128.PubMedGoogle Scholar
  95. Mayeux, R., Brandt, J., Rosen, J., & Benson, F. (1980). Interictal memory and language impairment in temporal lobe epilepsy. Neurology, 30, 120-125.PubMedGoogle Scholar
  96. Meador, K. J., Loring, D. W., Huh, K., Gallagher, B. B., & King, D. W. (1990). Comparative cognitive effects of anticonvulsants. Neurology, 40, 391-394.PubMedGoogle Scholar
  97. Milner, B. (1975). Hemispheric specialization: Scope and limits. In B. Milner (Ed.), Hemispheric specialization and interaction (pp. 75-89). Cambridge, MA: MIT Press.Google Scholar
  98. Mirsky, A. F., Primoc, D. W., Ajmone-Marsan, C. A., Rosvold, H. E., & Stevens, J. R. (1960). A comparison of the psychological test performance of patients with focal and nonfocal epilepsy. Experimental Neurology, 2, 75-89.PubMedGoogle Scholar
  99. Mirsky, A. F., & Van Buren, J. M. (1965). On the nature of the “absence” in centrencephalic epilepsy: A study of some behavioral, electroencephalographic, and autonomic factors. Electroencephalography and Clinical Neurophysiology, 18, 334-348.PubMedGoogle Scholar
  100. Morgan, A., & Groh, C. (1980). Changes in visual perception in children with epilepsy. In B. Kulig, H. Meinardi, & G. Stores (Eds.), Epilepsy and behavior ‘79. Lisse: Swets & Zeitlinger.Google Scholar
  101. Mumford, J. P., Beaumont, D., & Gisselbrecht, D. (1990). Cognitive function, mood, and behaviour in vigabatrin treated patients. Acta Neurologica Scandinavica, 82(Suppl. 133), 15.Google Scholar
  102. National Institutes of Health. (1990). Consensus development conference on surgery for epilepsy (NIH Publication No. HE20.3615/2:90-1). Washington, DC: U.S. Department of Health and Human Services.Google Scholar
  103. Nellhaus, G. (1971). The ketogenic diet reconsidered (abstract). Neurology, 21, 424.Google Scholar
  104. Novelly, R. A., Augustine, E. A., Mattson, R. H., Glaser, G. H., Williamson, P. D., Spencer, D. D., et al. (1984). Selective memory improvement and impairment in temporal lobectomy for epilepsy. Annals of Neurology, 15, 64-67.PubMedGoogle Scholar
  105. O'Leary, D. S., Lovell, M. R., Sackellares, J. C., Berent, S., Giordani, B., Seidenberg, M., et al. (1983). Effects of age of onset of partial and generalized seizures on neuropsychological performance in children. Journal of Nervous and Mental Disease, 171(10), 624-629.PubMedGoogle Scholar
  106. Painter, M. J., & Gaus, L. M. (1993). Phenobarbital in seizure disorders. In E. Wyllie (Ed.), The treatment of epilepsy: Principles and practices (pp. 900-908). Philadelphia: Lea & Febiger.Google Scholar
  107. Pellock, J. M. (1994). The use of new anticonvulsant drugs in children. In M. R. Trimble (Ed.), New anticonvulsants: Advances in the treatment of epilepsy. (pp. 127-143). New York: Wiley.Google Scholar
  108. Post, R. M. (1983). Behavioral effects of kindling. In M. Parsonage (Ed.), Advances in epileptology: XIV international symposium (pp. 173-180). New York: Raven Press.Google Scholar
  109. Quadfasel, A. F., & Pruyser, P. W. (1955). Cognitive deficits in patients with psychomotor epilepsy. Epilepsia, 4, 80-90.PubMedGoogle Scholar
  110. Ramsay, R. E., & Slater, J. D. (1993). Antiepileptic drugs in clinical development. In J. A. French, M. A. Dichter, & I. E. Leppick (Eds.), New antiepileptic drug development: Preclinical and clinical aspects (Epilepsy research suppl. 10, pp. 45-67). Amsterdam: Elsevier.Google Scholar
  111. Reitan, R. M. (1974). Psychological testing of epileptic patients. In O. Magnus & L. de Hass (Eds.), The handbook of clinical neurology: Vol. 15. The epilepsies (pp. 559-575). Amsterdam: Elsevier.Google Scholar
  112. Reitan, R. M., & Wolfson, D. (1993). The Halstead-Reitan Neuropsychological Test Battery: Theory and clinical interpretation (2 nd ed.) Tucson, AZ: Neuropsychology Press.Google Scholar
  113. Reynolds, E. H. (1983). Mental effects of antiepileptic medication: A review. Epilepsia, 24(Suppl. 2), 85-96.Google Scholar
  114. Reynolds, E. H. (1985). Antiepileptic drugs and psychopathology. In M. R. Trimble (Ed.), The psycho pharma cology of epilepsy (pp. 49-63). New York: Wiley.Google Scholar
  115. Reynolds, E. H., Ring, H. A., Farr, I. N., Heller, A. J., & Elwes, R. D. (1991). Open, double-blind, and long-term study of vigabatrin in chronic epilepsy. Epilepsia, 32(4), 530-538.PubMedGoogle Scholar
  116. Reynolds, E. H., & Travers, R. D. (1974). Serum anticonvulsant concentrations in epileptic patients with mental symptoms. British Journal of Psychiatry, 124, 440-445.PubMedGoogle Scholar
  117. Reynolds, E. H., & Trimble, M. R. (1985). Adverse neuropsychiatric effects of anticonvulsant drugs. Drugs, 29, 570-581.PubMedGoogle Scholar
  118. Richens, A., & Yuen, A. W. C. (1991). Overview of the clinical efficacy of lamotrigine. Epilepsia, 32(Suppl. 2), S13-S16.PubMedGoogle Scholar
  119. Ring, H. A., Heller, A. J., Farr, I. N., & Reynolds, E. H. (1990). Vigabatrin: Rational treatment for chronic epilepsy. Journal of Neurology, Neurosurgery, and Psychiatry, 53(12), 1051-1055.PubMedGoogle Scholar
  120. Rodin, E. (1984). Epileptic and pseudoepileptic seizures: Differential diagnostic considerations. In D. Blumer (Ed.), Psychiatric aspects of epilepsy (pp. 179-195). Washington, DC: American Psychiatric Press.Google Scholar
  121. Roger, J., Grangeon, H., Guey, J., & Lob, H. (1968). Psychiatric and psychological effects of ethosuximide treatment in epileptics. Encephale, 57, 407-438.PubMedGoogle Scholar
  122. Rutter, M., Graham, P., & Yule, W. (1970). A neuropsychological study in childhood. Clinics in Developmental Medicine, 35/36. London: S. I. M. P. & Heinemann.Google Scholar
  123. Saletu, B., Grunberger, J., & Linzmayer, L. (1986). Evaluation of encephalotropic and psychotropic properties of gabapentin in man by pharmaco-EEG and psychometry. International Journal of Clinical Pharmacology and Toxicology, 24, 362-373.Google Scholar
  124. Scarpa, P., & Carassini, B. (1982). Partial epilepsy in childhood: Clinical and EEG study in 261 cases. Epilepsia, 23, 333-341.PubMedGoogle Scholar
  125. Schain, R. J., Ward, J. W., & Guthrie, D. (1977). Carbamazepine as an anticonvulsant in children. Neurology, 27, 476-480.PubMedGoogle Scholar
  126. Schlumberger, E., Chavez, F., Palacios, L., Rey, E., Pajot, N., & Dulac, O. (1994). Lamotrigine in treatment of 120 children with epilepsy. Epilepsia, 35(2), 359-367.PubMedGoogle Scholar
  127. Schmidt, B. (1989). Potential antiepileptic drugs. I. Gabapentin. In R. Levy, R. Mattson, B. Meldrum, J. K. Penry, & F. E. Dreifuss (Eds.), Antiepileptic drugs (3rd ed., pp. 925-935). New York: Raven Press.Google Scholar
  128. Schwartz, M. L., & Dennerll, R. D. (1970). Neuropsychological assessment of children with and without questionable epileptogenic dysfunction. Perceptual and Motor Skills, 30, 111-121.PubMedGoogle Scholar
  129. Schwartz, R. H., Boyes, S., & Aynsley-Green, A. (1989). Metabolic effects of three ketogenic diets in the treatment of severe epilepsy. Developmental Medicine and Child Neurology, 31, 152-160.PubMedGoogle Scholar
  130. Schwartz, R. H., Eaton, J., Bower, B. D., & Aynsley-Green, A. (1989). Ketogenic diets in the treatment of epilepsy: Short-term clinical effects. Developmental Medicine and Child Neurology, 31, 145-151.PubMedGoogle Scholar
  131. Scott, D., Moffett, A., Matthews, A., & Ettlinger, G. (1967). Effects of epileptic discharges on learning and memory in patients. Epilepsia, 8, 188-194.PubMedGoogle Scholar
  132. Shorvon, S. D., & Reynolds, E. H. (1979). Reduction of polypharmacy for epilepsy. British Medical Journal, 2, 1023-1025.PubMedGoogle Scholar
  133. Sillanpää, M. (1993). Carbamazepine. In E. Wyllie (Ed.), The treatment of epilepsy: Principles and practices (pp. 867-886). Philadelphia: Lea & Febiger.Google Scholar
  134. Sivenius, J., Kalviainen, R., Ylinen, A., & Riekkinen, R. (1991). Double-blind study of gabapentin in the treatment of partial seizures. Epilepsia, 32, 539-542.PubMedGoogle Scholar
  135. Somerfield-Ziskind, E., & Ziskind, E. (1940). Effect of phenobarbital on the mentality of epileptic patients. Archives of Neurology and Psychiatry, 43, 70-79.Google Scholar
  136. Sterman, M. B. (1993). Sensorimotor EEG feedback training in the study and treatment of epilepsy. In D. I. Mostofsky & Y. Løyning (Eds.), The neurobehavioral treatment of epilepsy (pp. 1-18). Hillsdale, NJ: Erlbaum.Google Scholar
  137. Sterman, M. B., & Bloomfield, S. (1987). Limbic neuronal discharge correlates of sensorimotor EEG feedback training in presurgical patients with intractable epilepsy. In D. I. Mostofsky & Y. Løyning (Eds.), The neurobehavioral treatment of epilepsy (pp. 1-18). Hillsdale, NJ: Erlbaum.Google Scholar
  138. Sterman, M. B., & Friar, L. R. (1972). Suppression of seizures in an epileptic following sensorimotor EEG feedback training. Electroencephalography and Clinical Neurophysiology, 33, 89-95.PubMedGoogle Scholar
  139. Stores, G. (1973). Studies of attention and seizure disorders. Developmental Medicine and Child Neurology, 15, 376-382.PubMedGoogle Scholar
  140. Stores, G. (1981). Problems of learning and behavior in children with epilepsy. In E. H. Reynolds & M. R. Trimble (Eds.), Epilepsy and psychiatry (pp. 33-48). Edinburgh: Churchill Livingstone.Google Scholar
  141. Tartara, A., Manni, R., Galimberti, C. A., Mumford, J. P., Iudice, A. S., & Perucca, E., (1989). Vigabatrin in the treatment of epilepsy: A long-term follow-up study. Journal of Neurology, Neurosurgery, and Psychiatry, 52, 467-471.PubMedGoogle Scholar
  142. Tarter, R. E. (1972). Intellectual and adaptive functioning in epilepsy: A review of 50 years of research. Diseases of the Nervous System, 33, 763-770.PubMedGoogle Scholar
  143. Thompson, P. J., Huppert, F. A., & Trimble, M. R. (1981). Phenytoin and cognitive function: Effects on normal volunteers and implication for epilepsy. British Journal of Clinical Psychology, 20, 155-162.PubMedGoogle Scholar
  144. Thompson, P. J., & Trimble, M. R. (1982). Anticonvulsant drugs and cognitive functions. Epilepsia, 23, 531-544.PubMedGoogle Scholar
  145. Tizard, J., Rutter, M., & Whitmore, K. (1969). Education, health, and behavior. London: Longmans.Google Scholar
  146. Trimble, M. (1981). Anticonvulsant drugs, behavior, and cognitive abilities. Current Developments in Psychopharmacology, 6, 65-91.PubMedGoogle Scholar
  147. Trimble, M. R. (Ed.). (1994). New anticonvulsants: Advances in the treatment of epilepsy. New York: Wiley.Google Scholar
  148. Trimble, M. R., & Corbett, J. A. (1980). Behavioral and cognitive disturbances in epileptic children. Irish Medical Journal, 73, 21-28.Google Scholar
  149. Trimble, M. R., & Reynolds, E. H. (1976). Anticonvulsant drugs and mental symptoms. Psychological Medicine, 6, 169-178.PubMedGoogle Scholar
  150. Trimble, M. R., & Thompson, P. J. (1981). Memory, anticonvulsant drugs, and seizures. Acta Neurological Scandinavica, 89, 31-41.Google Scholar
  151. Trimble, M. R., & Thompson, P. J. (1984). Sodium valproate and cognitive function. Epilepsia, 25(Suppl. 1), 560-564.Google Scholar
  152. Trimble, M. R., & Thompson, P. J. (1986). Neuropsychological aspects of epilepsy. In I. Grant & K. M. Adams (Eds.), Neuropsychological assessment of neuropsychiatric disorders (pp. 321-346). London: Oxford University Press.Google Scholar
  153. Turner, W. A. (1907). Epilepsy. London: Macmillan & Co.Google Scholar
  154. Tymchuk, A. J. (1974). Comparison of Bander error and time scores for groups of epileptic, retarded, and behavior-problem children. Perceptual and Motor Skills, 38, 71-74.PubMedGoogle Scholar
  155. Vajda, F. J. E. (1992). New anticonvulsants. Current Opinions in Neurology and Neurosurgery, 5, 519-525.Google Scholar
  156. Wagner, M. L. (1994). Felbamate: A new antiepileptic drug. American Journal of Hospital Pharmacy, 51(13), 1657-1666.PubMedGoogle Scholar
  157. Walker, A. E., & Blumer, D. (1984). Behavioral effects of temporal lobectomy for temporal lobe epilepsy. In D. Blumer (Ed.), Psychiatric aspects of epilepsy (pp. 295-323). Washington, DC: American Psychiatric Press.Google Scholar
  158. Wallace, S. J. (1990). Add-on open trial of lamotrigine on resistant childhood seizures. Eighteenth ICNA meeting, Tokyo, p. 734.Google Scholar
  159. Waxman, S. A., & Geschwind, N. (1984). Hypergraphia in temporal lobe epilepsy. Neurology, 30, 314-317.Google Scholar
  160. Wilensky, A. J., Temkin, N. R., Ojeman, L. M., Rischer, B., & Holubkov, A. (1992). Gabapentin and carbamazepine as monotherapy and combined: A pilot study (Abstract). Epilepsia, 33, 77.Google Scholar
  161. Wilkus, R. J., & Dodrill, C. B. (1976). Neuropsychological correlates of the EEG in epileptics. I. Topographic distribution and average rate of epileptiform activity. Epilepsia, 17, 89-100.PubMedGoogle Scholar
  162. Wilson, A., Petty, R., Perry, A., & Rose, R. C. (1983). Paroxysmal language disturbance in an epileptic treated with clobazan. Neurology, 33, 652-654.PubMedGoogle Scholar
  163. Wolf, S. M., & Forsythe, A. (1978). Behavior disturbance, phenobarbital, and febrile seizures. Pediatrics, 61, 728-731.PubMedGoogle Scholar
  164. Wyllie, E. (Ed.). (1993). The treatment of epilepsy: Principles and practices. Philadelphia: Lea & Febiger.Google Scholar
  165. Wyrwicka, W., & Sterman, M. B. (1968). Instrumental conditioning of sensorimotor cortex EEG spindles in the waking cat. Physiology and Behavior, 3, 703-707.Google Scholar
  166. Zimmerman, F. T., Burgemeister, B. B., & Putnam, T. J. (1951). Intellectual and emotional makeup of the epileptic. Archives of Neurology and Psychiatry, 65, 545-556.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Thomas L. Bennett
    • 1
  • Maile R. Ho
    • 1
  1. 1.Department of PsychologyColorada State UniversityFt. CollinsUSA

Personalised recommendations